Dr Lal PathLabs preps $95m India IPO
fivepointsix - Fotolia
India’s Dr Lal PathLabs has firmed up terms for its Rp6.32bn ($95m) IPO, with the small size of the transaction giving leads the confidence of a positive response when the deal launches.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: